Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases

ACS Infectious Diseases(2025)10.1021/acsinfecdis.5c00860Source: DataRank Database

Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases is a research paper published in ACS Infectious Diseases (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: hybridTopics (17)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Stephanie Halasohoris,Annette Gray,Jennifer Chua ORCID,Jade L. Spencer,B Curry

Live enrichment

PubMed:41430688 PMC:PMC12797228

Division of Microbiology and Infectious Diseases

Grant: R01 AI170546

Division of Microbiology and Infectious Diseases

Grant: R01 AI173072

Defense Threat Reduction Agency

Grant: CB11395

National Institute of General Medical Sciences

Grant: R01 GM126363

JobsOhio Early-Stage Technology Fund

hybridLicense: cc-by

publisherhttps://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.5c00860?ref=article_openPDF

publisherhttps://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.5c00860

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12797228/

Europe_PMChttps://europepmc.org/articles/PMC12797228

Europe_PMChttps://europepmc.org/articles/PMC12797228?pdf=render

MeSH Terms

AnimalsRabbitsBacillus anthracisAnthraxCiprofloxacinDNA Topoisomerases, Type IIDNA GyraseAnti-Bacterial AgentsMicrobial Sensitivity TestsTopoisomerase InhibitorsTopoisomerase II Inhibitors

Keywords

Bacillus anthracisanthraxTopoisomerase IvGyraseGepotidacinOsuab-0284

Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases

FAIR Checklist

Authors (13)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)